Inhibrx Biosciences IncNASDAQ:INBX
- LAST PRICE14.1700
- TODAY'S CHANGE (%)0.1100 (0.7824%)
- Bid / Lots13.7500/ 2
- Ask / Lots14.8100/ 1
- Open / Previous Close14.0400 / 14.0600
- Day Range
- 52 Week Range
- Volume823,828
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | INBX |
|---|---|---|
| 09:32 ET | 3059 | 14.5 |
| 09:34 ET | 200 | 14.55 |
| 09:38 ET | 378 | 14.0798 |
| 09:41 ET | 100 | 14.12 |
| 09:48 ET | 400 | 14.17 |
| 09:50 ET | 403 | 14.13 |
| 09:52 ET | 100 | 14.3 |
| 09:54 ET | 400 | 14.2 |
| 09:56 ET | 100 | 14.38 |
| 10:01 ET | 200 | 14.43 |
| 10:06 ET | 100 | 14.5 |
| 10:08 ET | 100 | 14.5 |
| 10:14 ET | 205 | 14.5 |
| 10:17 ET | 100 | 14.5 |
| 10:21 ET | 300 | 14.37 |
| 10:24 ET | 500 | 14.27 |
| 10:26 ET | 500 | 14.18 |
| 10:28 ET | 2971 | 14.17 |
| 10:30 ET | 300 | 14.15 |
| 10:32 ET | 700 | 14.15 |
| 10:33 ET | 500 | 14.155 |
| 10:35 ET | 544 | 14.21 |
| 10:37 ET | 200 | 14.24 |
| 10:39 ET | 700 | 14.265 |
| 10:44 ET | 200 | 14.265 |
| 10:48 ET | 100 | 14.29 |
| 10:50 ET | 100 | 14.265 |
| 10:57 ET | 300 | 14.285 |
| 11:00 ET | 3861 | 14.14 |
| 11:02 ET | 200 | 14.135 |
| 11:06 ET | 100 | 14.135 |
| 11:09 ET | 2000 | 14.22 |
| 11:11 ET | 300 | 14.14 |
| 11:13 ET | 700 | 14.19 |
| 11:15 ET | 500 | 14.105 |
| 11:18 ET | 400 | 14.04 |
| 11:20 ET | 1000 | 14.16 |
| 11:22 ET | 200 | 14.15 |
| 11:24 ET | 600 | 14.17 |
| 11:26 ET | 372 | 14.22 |
| 11:27 ET | 200 | 14.18 |
| 11:29 ET | 900 | 14.155 |
| 11:31 ET | 1504 | 14.15 |
| 11:33 ET | 300 | 14.155 |
| 11:36 ET | 700 | 14.22 |
| 11:40 ET | 200 | 14.15 |
| 11:42 ET | 300 | 14.21 |
| 11:44 ET | 496 | 14.13 |
| 11:45 ET | 822 | 14.1 |
| 11:47 ET | 500 | 14.075 |
| 11:49 ET | 663 | 13.96 |
| 11:51 ET | 100 | 14 |
| 11:54 ET | 552 | 13.995 |
| 11:56 ET | 1320 | 13.99 |
| 11:58 ET | 100 | 13.995 |
| 12:03 ET | 100 | 13.995 |
| 12:05 ET | 300 | 14.05 |
| 12:09 ET | 100 | 14.04 |
| 12:12 ET | 1100 | 14.17 |
| 12:14 ET | 400 | 14.205 |
| 12:18 ET | 200 | 14.19 |
| 12:21 ET | 300 | 14.14 |
| 12:27 ET | 650 | 14.13 |
| 12:41 ET | 200 | 14.17 |
| 12:43 ET | 175 | 14.2 |
| 12:48 ET | 500 | 14.2 |
| 12:52 ET | 300 | 14.17 |
| 12:57 ET | 200 | 14.17 |
| 01:03 ET | 200 | 14.12 |
| 01:08 ET | 100 | 14.15 |
| 01:10 ET | 100 | 14.11 |
| 01:12 ET | 200 | 14.1 |
| 01:15 ET | 100 | 14.11 |
| 01:17 ET | 100 | 14.09 |
| 01:19 ET | 300 | 14.075 |
| 01:21 ET | 450 | 14.045 |
| 01:24 ET | 400 | 13.995 |
| 01:26 ET | 200 | 13.92 |
| 01:28 ET | 300 | 13.91 |
| 01:30 ET | 2917 | 13.91 |
| 01:32 ET | 400 | 13.9 |
| 01:33 ET | 100 | 13.88 |
| 01:35 ET | 2273 | 13.77 |
| 01:37 ET | 1819 | 13.77 |
| 01:39 ET | 300 | 13.78 |
| 01:42 ET | 1749 | 13.88 |
| 01:44 ET | 740 | 13.8901 |
| 01:48 ET | 100 | 13.87 |
| 01:50 ET | 600 | 13.99 |
| 01:51 ET | 926 | 13.98 |
| 01:55 ET | 100 | 13.84 |
| 02:00 ET | 100 | 13.885 |
| 02:02 ET | 200 | 13.93 |
| 02:04 ET | 200 | 13.94 |
| 02:06 ET | 629 | 13.94 |
| 02:08 ET | 100 | 13.88 |
| 02:09 ET | 400 | 13.95 |
| 02:11 ET | 100 | 14.03 |
| 02:13 ET | 300 | 14.06 |
| 02:15 ET | 200 | 14.07 |
| 02:20 ET | 600 | 14.09 |
| 02:22 ET | 100 | 14.19 |
| 02:24 ET | 300 | 14.17 |
| 02:26 ET | 100 | 14.14 |
| 02:27 ET | 100 | 14.19 |
| 02:29 ET | 100 | 14.19 |
| 02:31 ET | 200 | 14.15 |
| 02:33 ET | 100 | 14.15 |
| 02:40 ET | 400 | 14.15 |
| 02:42 ET | 1120 | 14.155 |
| 02:44 ET | 496 | 14.045 |
| 02:51 ET | 300 | 14.09 |
| 02:56 ET | 394 | 14.15 |
| 02:58 ET | 100 | 14.15 |
| 03:00 ET | 100 | 14.16 |
| 03:02 ET | 100 | 14.15 |
| 03:03 ET | 200 | 14.14 |
| 03:05 ET | 400 | 14.16 |
| 03:07 ET | 300 | 14.14 |
| 03:09 ET | 100 | 14.14 |
| 03:12 ET | 317 | 14.115 |
| 03:14 ET | 3132 | 14.095 |
| 03:18 ET | 100 | 13.995 |
| 03:20 ET | 2200 | 13.985 |
| 03:21 ET | 610 | 14.02 |
| 03:23 ET | 300 | 14.03 |
| 03:25 ET | 900 | 14.05 |
| 03:27 ET | 400 | 14.14 |
| 03:30 ET | 400 | 14.16 |
| 03:32 ET | 525 | 14.11 |
| 03:34 ET | 941 | 14.09 |
| 03:38 ET | 500 | 14.11 |
| 03:39 ET | 100 | 14.13 |
| 03:41 ET | 7164 | 14.13 |
| 03:43 ET | 500 | 14.17 |
| 03:45 ET | 11061 | 14.15 |
| 03:48 ET | 3325 | 14.13 |
| 03:50 ET | 2380 | 14.16 |
| 03:52 ET | 43508 | 14.265 |
| 03:54 ET | 7755 | 14.37 |
| 03:56 ET | 22425 | 14.22 |
| 03:57 ET | 22853 | 14.13 |
| 03:59 ET | 368888 | 14.17 |
May 30, 2024
*DJ News On Inhibrx Biosciences Inc. (INXBV) Now Under INXB, from 5:08PM ET on Thursday May 30, 2024 by Dow Jones
5:08PM ET on Thursday May 30, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Inhibrx Biosciences Inc | 205.1M | -2.6x | --- |
Century Therapeutics Inc | 212.1M | -1.1x | --- |
Inovio Pharmaceuticals Inc | 209.4M | -1.5x | --- |
Fractyl Health Inc | 204.5M | -2.5x | --- |
Gossamer Bio Inc | 203.8M | -0.9x | --- |
Q32 Bio Inc | 214.4M | -0.7x | --- |
Company Information
Inhibrx Biosciences, Inc. is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. The Company’s clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106. INBRX-109 is a tetravalent agonist of death receptor 5 (DR5) that is designed with its proprietary single domain antibody, or sdAb, platform to drive cancer-selective programmed cell death and to maximize potency while minimizing on-target liver toxicity arising from hepatocyte apoptosis. INBRX-106 is a hexavalent OX40 agonist, being investigated as a single agent and in combination with Keytruda, a PD-1 blocking checkpoint inhibitor, in patients with locally advanced or metastatic solid tumors. INBRX-106 is a precisely engineered hexavalent sdAb-based therapeutic candidate targeting OX40, designed to be an optimized agonist of this co-stimulatory receptor.
Contact Information
- Headquarters
- 11025 N. Torrey Pines Road, Suite 140LA JOLLA, CA, United States 92037
- Phone
- 858-795-4220
- Fax
- 302-636-5454
Executives
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $205.1M |
|---|---|
Revenue (TTM) | $1.8M |
Shares Outstanding | 14.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-5.35 |
Book Value | $0.92 |
P/E Ratio | -2.6x |
Price/Sales (TTM) | 115.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -13,980.93% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
